Note that some links may require registration or subscription.
Tests designed to identify the past use of abortion drugs — under development in Poland — are raising concerns. (Nature)
A kidney transplant from a gene-edited pig kept a monkey alive for 2 years, suggesting the use of porcine organs in humans is getting closer. (Nature)
Meanwhile, an artificial intelligence (AI) tool showed promise for helping diagnose brain tumors during surgery, thereby allowing surgeons to determine how aggressive to go with their resections. (Nature)
A new prosthetic technique has provided a Swedish woman with a functioning bionic hand. (Science Robotics)
Labcorp is now marketing its blood-based amyloid-tau-neurodegeneration test (ATN Profile) to U.S. doctors to help determine which patients under evaluation for possible Alzheimer’s disease need advanced testing.
However, medical experts say it will be several years before blood tests for Alzheimer’s become an everyday tool in the clinic. (Reuters)
In North Carolina, a family and doctor are suing to block the state’s ban on gender-affirming care. (The Hill)
Climate change’s threat to the mental health of children can start before birth, according to a report from the American Psychological Association.
The Consumer Product Safety Commission voted unanimously to advance safety regulations for infant rockers that have been linked to nearly a dozen deaths. (NBC News)
Three female physicians at Harbor-UCLA Medical Center are suing, claiming that years of complaints alleging sexual harassment, retaliation, and discriminatory behavior by orthopedic surgeon Louis Kwong, MD, were ignored. (NBC News)
A doctor in Virginia prescribed a new cat to a “very, very sad” woman when he became concerned about her overall well-being. (People)
Care Access, a U.S. network of research sites, said an FDA inspection found no misconduct related to its activities in a phase III trial of a Lyme disease vaccine candidate; the study was discontinued at the network’s sites after developer Pfizer cited a breach of clinical trial guidelines.
The FDA approved encorafenib (Braftovi) with binimetinib (Mektovi) for treating metastatic non-small cell lung cancer patients whose tumors harbor a BRAF V600E mutation.
And the agency approved an expanded indication of the WaveWriter Alpha Spinal Cord Stimulator Systems for the treatment of painful diabetic peripheral neuropathy, Boston Scientific announced.
FDA also cleared TriLEAP, a low-profile plating system used to cover forefoot, midfoot, and hindfoot elective and trauma procedures, Johnson & Johnson announced.
And in other agency news, the FDA has created a new Digital Health Advisory Committee to explore the complex scientific and technical issues related to digital health technologies, such as AI and machine learning.
GSK settled four lawsuits claiming its heartburn drug ranitidine (Zantac) caused cancer. (Fox Business)
How do doctors handle in-flight emergencies? (Washington Post)
The World Health Organization has updated its guidance on adolescent health and well-being.
India has allowed the cough syrup factory tied to 65 deaths in Uzbekistan last year to resume production. (Reuters)